Antidepressants for depression in adults with HIV infection

Elliot, 2002, The effect of changes in depression on health related quality of life (HRQoL) in HIV infection, General Hospital Psychiatry, 24, 43, 10.1016/S0163-8343(01)00174-8

Elliot, 1998, Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients, American Journal of Psychiatry, 155, 367

Hoare, 2014, Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study. Journal of nervous and mental disease, Journal of Nervous and Mental Disease, 202, 133, 10.1097/NMD.0000000000000082

Mauri, 1994, A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients: short-term and perspective results, Integrative Psychiatry, 10, 199

Patel, 2013, Escitalopram and mirtazapine for the treatment of depression in HIV patients: a randomized controlled open label trial, ASEAN Journal of Psychiatry, 14, 31

Rabkin, 1994, Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness, American Journal of Psychiatry, 151, 516, 10.1176/ajp.151.4.516

Rabkin, 1999, Fluoxetine treatment for depression in patients with HIV and Aids: a randomized, placebo-controlled trial, American Journal of Psychiatry, 156, 101, 10.1176/ajp.156.1.101

Wagner, 1998, Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients, Psychiatric Services (Washington, D.C.), 49, 239, 10.1176/ps.49.2.239

Rabkin, 2004, Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS. A placebo-controlled trial, Clinical Psychopharmacology, 24, 379, 10.1097/01.jcp.0000132442.35478.3c

Schwartz, 1999, Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study, Depression and Anxiety, 9, 70, 10.1002/(SICI)1520-6394(1999)9:2<70::AID-DA4>3.0.CO;2-L

Targ, 1994, Structured group therapy and fluoxetine to treat depression in HIV-positive persons, Psychosomatics, 35, 132, 10.1016/S0033-3182(94)71786-2

Zisook, 1998, Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group, Journal of Clinical Psychiatry, 59, 217, 10.4088/JCP.v59n0502

Brown, 2016, Effective treatment of depressive disorders in medical clinics for adolescents and young adults living with HIV: a controlled trial, Journal of Acquired Immune Deficiency Syndromes, 71, 38, 10.1097/QAI.0000000000000803

Chibanda, 2014, Group problem-solving therapy for postnatal depression among HIV-positive and HIV-negative mothers in Zimbabwe, Journal of the International Association of Providers of AIDS Care, 13, 335, 10.1177/2325957413495564

Markowitz, 1998, Treatment of depressive symptoms in human immunodeficiency virus-positive patients, Archives of General Psychiatry, 55, 452, 10.1001/archpsyc.55.5.452

Marmor Drug abuse, depression and responses to HIV counseling clinicaltrials.gov/show/NCT00285584

Pence, 2015, The effect of antidepressant treatment on HIV and depression outcomes: the SLAM DUNC randomized trial, AIDS, 19, 1975, 10.1097/QAD.0000000000000797

NCT00228007 Antidepressant medication for reducing HIV risk behavior in depressed intravenous drug users clinicaltrials.gov/show/NCT00228007

Stein, 2005, Reductions in HIV risk behaviors among depressed drug injectors, American Journal of Drug and Alcohol Abuse, 31, 417, 10.1081/ADA-200056793

Grelotti DJ Hammer GP Dilley JW Karasic DH Sorensen JL Bangsberg DR Does substance use compromise depression treatment? A randomized trial of homeless HIV+ persons 21st Conference on Retroviruses and Opportunistic Infections, CROI; 2014 Mar 3-6; Boston (MA) 2014

Tsai, 2013, Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial, American Journal of Public Health, 103, 308, 10.2105/AJPH.2011.300422

NCT02620150 SSRI effects on depression and immunity in HIV/AIDS clinicaltrials.gov/show/NCT02620150

Akena, 2012, The association between AIDS related stigma and major depressive disorder among HIV-positive individuals in Uganda, PloS One, 7, e48671, 10.1371/journal.pone.0048671

Ammassari, 2004, Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons, Psychosomatics, 45, 394, 10.1176/appi.psy.45.5.394

American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596

Beck, 1961, "Beck Depression Inventory (BDI)", Archives of General Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004

Bing, 2001, Psychiatric disorders and drug use among human Immunodeficiency virus-Infected adults in the United States, Archives of General Psychiatry, 58, 721, 10.1001/archpsyc.58.8.721

Cavalcante, 2010, Implications of efavirenz for neuropsychiatry: a review, International Journal of Neuroscience, 120, 739, 10.3109/00207454.2010.520541

Schneider E Whitmore S Glynn MK Dominguez K Mitsch A McKenna MT Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years - United States, 2008 MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report 2008 1 12

Cespedes, 2006, Neuropsychiatric complications of antiretroviral therapy, Drug Safety, 29, 865, 10.2165/00002018-200629100-00004

Chibanda, 2015, Psychological interventions for common mental disorders for people living with HIV in low- and middle-income countries: systematic review, Tropical Medicine and International Health, 20, 830, 10.1111/tmi.12500

Ciesla, 2001, Meta-analysis of the relationship between HIV infection and risk for depressive disorders, American Journal of Psychiatry, 158, 725, 10.1176/appi.ajp.158.5.725

Cohen, 1988, Statistical Power Analysis for the Behavioral Sciences

Cohen, 2001, Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection, Clinical Infectious Diseases, 32, 1756, 10.1086/320759

Collins, 2006, What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review, AIDS, 20, 1571, 10.1097/01.aids.0000238402.70379.d4

Connell, 2014, Measuring quality of life in mental health: are we asking the right questions?, Social Science and Medicine, 120, 12, 10.1016/j.socscimed.2014.08.026

Cruess, 2003, Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease, Biological Psychiatry, 54, 307, 10.1016/S0006-3223(03)00318-4

National Institute of Allergy and Infectious Diseases Division of AIDS table for grading the severity of adult and pediatric adverse events version 1.0, December 2004; clarification August 2009 rsc.tech-res.com/docs/default-source/safety/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf

Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org

Guerra, 2013, Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways, Journal of Neurovirology, 19, 314, 10.1007/s13365-013-0177-7

DeSilva, 2001, Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine, AIDS, 15, 1281, 10.1097/00002030-200107060-00010

Dew, 1997, Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation, Psychological Medicine, 27, 395, 10.1017/S0033291796004552

DiMatteo, 2000, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence, Archives of Internal Medicine, 160, 2101, 10.1001/archinte.160.14.2101

Eaton, 2004, Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R), The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 363

Elliott, 2002, The effect of changes in depression on health related quality of life (HRQoL) in HIV infection, General Hospital Psychiatry, 24, 43, 10.1016/S0163-8343(01)00174-8

Endicott, 1993, Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure, Psychopharmacology Bulletin, 29, 321

Fernandez, 1991, Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection, Psychiatric Medicine, 9, 377

Foley, 2008, Emerging issues in the neuropsychology of HIV infection, Current HIV/AIDS Reports, 5, 204, 10.1007/s11904-008-0029-x

Gaida, 2016, A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications, Expert Review of Anti-infective Therapy, 14, 377, 10.1586/14787210.2016.1157469

Gaynes, 2012, Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon, PloS One, 7, e41699, 10.1371/journal.pone.0041699

Ghafouri, 2006, HIV-1 associated dementia: symptoms and causes, Retrovirology, 3, 28, 10.1186/1742-4690-3-28

Gibbs, Aug 2016 [Epub ahead of print], An exploratory analysis of factors associated with depression in a vulnerable group of young people living in informal settlements in South Africa, Global Public Health, 1, 10.1080/17441692.2016.1214281

Gorman, 1991, Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection, American Journal of Psychiatry, 148, 41, 10.1176/ajp.148.1.41

Grant, 2008, Neurocognitive disturbances in HIV, International Review of Psychiatry, 20, 33, 10.1080/09540260701877894

Guy, 1976, ECDEU Assessment Manual for Psychopharmacology. Revised

Guyatt, 2011, GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables, Journal of Clinical Epidemiology, 64, 383, 10.1016/j.jclinepi.2010.04.026

Hamilton, 1980, Rating depressive patients, Journal of Clinical Psychiatry, 41, 21

Higgins, 2009, Cochrane Handbook of Systematic Reviews of Interventions

Higgins, 2010, Antidepressant-associated sexual dysfunction: impact, effects and treatment, Drug, Healthcare and Patient Safety, 2, 141, 10.2147/DHPS.S7634

Himelhoch, 2005, Efficacy of antidepressant medication among HIV positive individuals with depression: a systematic review and meta-analysis, AIDS Patient Care and STDs, 19, 813, 10.1089/apc.2005.19.813

Honagodu, 2013, Group psychotherapies for depression in persons with HIV: a systematic review, Indian Journal of Psychiatry, 55, 323, 10.4103/0019-5545.120541

Horberg, 2008, Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients, Journal of Acquired Immune Deficiency Syndromes, 47, 384, 10.1097/QAI.0b013e318160d53e

Huang, 1990, Natural killer cell responses in homosexual men with early HIV infection, Journal of Acquired Immune Deficiency Syndrome, 3, 669

Illa, 2014, Review of recent behavioural interventions targeting older adults living with HIV/AIDS, Current HIV/AIDS Reports, 11, 413, 10.1007/s11904-014-0231-y

Kinyanda, 2011, Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda, BioMed Central Psychiatry, 11, 205, 10.1186/1471-244X-11-205

Leserman, 1997, Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study, Archives of General Psychiatry, 54, 279, 10.1001/archpsyc.1997.01830150105015

Lichtenstein, 2002, Chronic sorrow in the HIV-positive patient: issues of race, gender, and social support, AIDS Patient Care and STDs, 16, 27, 10.1089/108729102753429370

Lima, 2007, The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART, AIDS, 21, 1175, 10.1097/QAD.0b013e32811ebf57

Machado, 2006, Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials, Current Medical Research and Opinion, 22, 1825, 10.1185/030079906X132415

McArthur, 2005, Neurological complications of HIV infection, Lancet Neurology, 4, 543, 10.1016/S1474-4422(05)70165-4

Montgomery, 1979, A new depression scale designed to be sensitive to change, British Journal of Psychiatry, 134, 382, 10.1192/bjp.134.4.382

Morrison, 2002, Depressive and anxiety disorders in women with HIV infection, American Journal of Psychiatry, 159, 789, 10.1176/appi.ajp.159.5.789

Nakasujja, 2010, Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda, BioMed Central Psychiatry, 10, 44, 10.1186/1471-244X-10-44

Nakimuli-Mpungu, 2011, Prevalence and factors associated with depressive disorders in an HIV positive rural patient population in southern Uganda, Journal of Affective Disorders, 135, 160, 10.1016/j.jad.2011.07.009

Nanni, 2015, Depression in HIV infected patients: a review, Current Psychiatry Reports, 17, 7

Nelson, 2009, Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials, American Journal of Psychiatry, 166, 980, 10.1176/appi.ajp.2009.09030312

National Institute for Health and Clinical Excellence Depression in adults: the treatment and management of depression in adults. 2009 (updated 2016) www.nice.org.uk/guidance/CG90

National Institute for Health and Care Excellence First-choice antidepressant use in adults with depression or generalised anxiety disorder, 2015 www.nice.org.uk/advice/ktt8/chapter/options-for-local-implementation

Nott, 1999, Nature and consequences of stressful life events in homosexual HIV-positive men: a review, AIDS Care, 11, 235, 10.1080/09540129948117

Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014

Rutherford, 2013, A model of placebo response in antidepressant clinical trials, American Journal of Psychiatry, 170, 723, 10.1176/appi.ajp.2012.12040474

Schuster, 2012, The influence of depression on the progression of HIV: direct and indirect effects, Behaviour Modification, 36, 123, 10.1177/0145445511425231

Siccardi, 2013, Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach, Clinical Pharmacokinetics, 52, 583, 10.1007/s40262-013-0056-7

Spitzer, 1999, Validation and utility of a self-report Version of PRIME-MD: the PHQ Primary Care Study, Journal of the American Medical Association, 282, 1737, 10.1001/jama.282.18.1737

Springer, 2012, The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review, AIDS Behaviour, 16, 2119, 10.1007/s10461-012-0212-3

Stein, 2006, Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram, Journal of Clinical Psychiatry, 67, 1741, 10.4088/JCP.v67n1111

Tuynman-Qua, 1997, Quality of Life in Depression Scale (QLDS). Development, reliability, validity, responsiveness and application, European Psychiatry, 12, 199, 10.1016/S0924-9338(97)89105-5

UNAIDS Fact sheet 2016 www.unaids.org/en/resources/fact-sheet

Unnikrishnan, 2012, Study of depression and its associated factors among women living with HIV/AIDS in coastal south India, International Scholarly Research Network AIDS, 2012, 1

United States Food Drug Administration Prescribing information SUSTIVA www.accessdata.fda.gov/drugsatfda_docs/label/2013/020972s043,021360s031lbl.pdf

United States Food Drug Administration Labeling Information KALETRA www.accessdata.fda.gov/drugsatfda_docs/label/2013/021226s038lbl.pdf

Uthman, 2014, Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis, Current HIV/AIDS Reports, 11, 291, 10.1007/s11904-014-0220-1

Wagner, 2014, The role of depression in work-related outcomes of HIV treatment in Uganda, International Journal of Behavioural Medicine, 21, 946, 10.1007/s12529-013-9379-x

Walsh, 2002, Placebo response in studies of major depression. Variable, substantial, and growing, JAMA, 287, 1840, 10.1001/jama.287.14.1840

World Health Organization, 1992, International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)

World Health Organization WHO mhGap guideline update, 2015 apps.who.int/iris/bitstream/10665/204132/1/9789241549417_eng.pdf?ua=1